4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-049255
President and CEO sold 3,479 shares at an average $5.23 ($18,196)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-08 | Sale : show line 1 in the form | −16 | $5.26 | $84 | 626,461 | D |
| 2022-09-08 | Sale : show line 2 in the form | −3,463 | $5.23 | $18,111 | 622,998 | D |
| Open-market sales · 3,479 sh · avg $5.23 · $18,196 | ||||||
Loading xslF345X03/doc4.xml…